XML 34 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities    
Net income $ 1,475 $ 1,408
Less: Net income attributable to noncontrolling interest 12 14
Net income attributable to Honeywell 1,463 1,394
Adjustments to reconcile net income attributable to Honeywell to net cash provided by (used for) operating activities    
Depreciation 166 161
Amortization 125 122
Repositioning and other charges 93 141
Net payments for repositioning and other charges (124) (41)
NARCO Buyout payment 0 (1,325)
Pension and other postretirement income (151) (136)
Pension and other postretirement benefit payments (8) (15)
Stock compensation expense 53 59
Deferred income taxes 3 225
Other (163) (350)
Changes in assets and liabilities, net of the effects of acquisitions and divestitures    
Accounts receivable 53 (422)
Inventories (140) (238)
Other current assets 64 110
Accounts payable (381) 114
Accrued liabilities (605) (583)
Net cash provided by (used for) operating activities 448 (784)
Cash flows from investing activities    
Capital expenditures (233) (193)
Proceeds from disposals of property, plant and equipment 0 11
Increase in investments (238) (226)
Decrease in investments 155 386
Receipts (payments) from settlements of derivative contracts 43 (7)
Net cash used for investing activities (273) (29)
Cash flows from financing activities    
Proceeds from issuance of commercial paper and other short-term borrowings 2,223 4,105
Payments of commercial paper and other short-term borrowings (2,470) (3,294)
Proceeds from issuance of common stock 144 37
Proceeds from issuance of long-term debt 5,710 0
Payments of long-term debt (573) (1,363)
Repurchases of common stock (671) (699)
Cash dividends paid (703) (725)
Other 36 (34)
Net cash provided by (used for) financing activities 3,696 (1,973)
Effect of foreign exchange rate changes on cash and cash equivalents (40) 28
Net increase (decrease) in cash and cash equivalents 3,831 (2,758)
Cash and cash equivalents at beginning of period 7,925 9,627
Cash and cash equivalents at end of period $ 11,756 $ 6,869